Pfizer said to offer €3 billion for Ratiopharm
This article was originally published in Scrip
Executive Summary
Pfizer is preparing to bid €3 billion for the German generics firm Ratiopharm, according to US press reports. Ratiopharm confirmed to Scrip that it is in negotiations with a possible buyer.